Measuring CSF shunt flow with MRI using flow enhancement of signal intensity ( FENSI )
Magnetic Resonance in Medicine · 2024
DOI: 10.1002/mrm.30079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2024. Verfasst von Mingxiao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Illinois Urbana-Champaign, Urbana, Illinois, USA. Hauptthemen laut MEDLINE: Phantoms, Imaging, Hydrocephalus, Magnetic Resonance Imaging, Cerebrospinal Fluid Shunts. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Purpose
To develop and validate a noninvasive imaging technique for accurately assessing very slow CSF flow within shunt tubes in pediatric patients with hydrocephalus, aiming to identify obstructions that might impede CSF drainage. Theory and Methods A simulation of shunt flow enhancement of signal intensity (shunt‐FENSI) signal is used to establish the relationship between signal change and flow rate. The quantification of flow enhancement of signal intensity data involves normalization, curve fitting, and calibration to match simulated data. Additionally, a phase sweep method is introduced to accommodate the impact of magnetic field inhomogeneity on the flow measurement. The method is tested in flow phantoms, healthy adults, intensive care unit patients with external ventricular drains (EVD), and shunt patients. EVDs enable shunt‐flow measurements to be acquired with a ground truth measure of CSF drainage.
Results
The flow‐rate‐to‐signal simulation establishes signal–flow relationships and takes into account the T 1 of draining fluid. The phase sweep method accurately accounts for phase accumulation due to frequency offsets at the shunt. Results in phantom and healthy human participants reveal reliable quantification of flow rates using controlled flows and agreement with the flow simulation. EVD patients display reliable measures of flow rates. Shunt patient results demonstrate feasibility of the method and consistent flow rates for functional shunts.
Conclusion
The results demonstrate the technique's applicability, accuracy, and potential for diagnosing and noninvasively monitoring hydrocephalus. Limitations of the current approach include a high sensitivity to motion and strict requirement of imaging slice prescription.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bioengineering, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.
- Beckman Institute, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.
- Carle Illinois College of Medicine, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.
- Department of Neurosurgery, Carle Foundation Hospital, Urbana, Illinois, USA.
- Department of Radiology, Carle Foundation Hospital, Urbana, Illinois, USA.
ORCID-Profile: Mingxiao Zhang, Aaron T Anderson, Bradley P Sutton
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Zhang, M., Olivero, W. C., Huston, J. M., Pappu, S., Arnold, P. M., Biswas, A., Anderson, A. T., & Sutton, B. P. (2024). Measuring CSF shunt flow with MRI using flow enhancement of signal intensity ( FENSI ). Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.30079
Vancouver
Zhang M, Olivero WC, Huston JM, Pappu S, Arnold PM, Biswas A, et al. Measuring CSF shunt flow with MRI using flow enhancement of signal intensity ( FENSI ). Magnetic Resonance in Medicine. 2024. doi:10.1002/mrm.30079
BibTeX
@article{Zhang2024,
author = {Zhang, Mingxiao and Olivero, William C and Huston, Jason M and Pappu, Suguna and Arnold, Paul M and Biswas, Arundhati and Anderson, Aaron T and Sutton, Bradley P},
title = {Measuring CSF shunt flow with MRI using flow enhancement of signal intensity ( FENSI )},
journal = {Magnetic Resonance in Medicine},
year = {2024},
doi = {10.1002/mrm.30079}
}
EUVIMED